Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity.
Cui YH, Wei J, Fan H, Li W, Zhao L, Wilkinson E, Peterson J, Xie L, Zou Z, Yang S, Applebaum MA, Kline J, Chen J, He C, He YY.
Cui YH, et al. Among authors: he c.
Proc Natl Acad Sci U S A. 2024 Dec 17;121(51):e2407910121. doi: 10.1073/pnas.2407910121. Epub 2024 Dec 11.
Proc Natl Acad Sci U S A. 2024.
PMID: 39661064